Proxeon has secured funding of DKK14m (GBP1.7m) from current venture capital investors and board members.
The proceeds are expected to be sufficient to reach positive cash flow.
Proxeon will report revenue growth in excess of 60 per cent for the 2008 financial year.
Marten Winge, chief executive officer at Proxeon, said: 'Since launch in 2006, we have shipped more than 100 of our novel Easy-nLC systems for nanoscale chromatography to leading proteomics laboratories around the world.
'Of particular note was the decision made by the Max Planck Institute in Martinsried, Germany to replace and standardise its nano LC instruments with Easy-nLC systems.'
